blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3511019

EP3511019 - THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  20.08.2021
Database last updated on 16.05.2026
FormerThe patent has been granted
Status updated on  11.09.2020
FormerGrant of patent is intended
Status updated on  02.06.2020
FormerRequest for examination was made
Status updated on  24.01.2020
FormerThe application has been published
Status updated on  14.06.2019
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
Pfizer Inc.
235 East 42nd Street
New York, NY 10017 / US
[2019/29]
Inventor(s)01 / BAGRODIA, Shubha
7936 Camino Tranquilo
San Diego, CA California 92122 / US
02 / LAFONTAINE, Jennifer
13444 Montecito Glen
San Diego, CA California 92130 / US
03 / LOVATT, Zach
41 Dayton Street
Danvers, MA Massachusetts 01923 / US
04 / SHIN, Eyoung
125 Dean Road
Marlborough, MA Massachusetts 01752 / US
05 / SONG, Young, Ho
33 Bradford Road
Natick, MA Massachusetts 01760 / US
06 / TROIANO, Greg
38 Lily's Way
Pembroke, MA Massachusetts 02359 / US
07 / WANG, Hong
27 Cottage Place
Newton, MA Massachusetts 02465 / US
 [2019/29]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2019/29]Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
Application number, filing date19156064.813.03.2015
[2019/29]
Priority number, dateUS201461953628P14.03.2014         Original published format: US 201461953628 P
[2019/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3511019
Date:17.07.2019
Language:EN
[2019/29]
Type: B1 Patent specification 
No.:EP3511019
Date:14.10.2020
Language:EN
[2020/42]
Search report(s)(Supplementary) European search report - dispatched on:EP23.05.2019
ClassificationIPC:A61K47/12, A61K47/28, A61K47/34, A61K9/107, A61K9/51, A61K31/5377
[2019/29]
CPC:
A61K31/5377 (EP,CN,EA,IL,KR,US); A61K9/5153 (EP,EA,KR,US); A61K9/5146 (CN);
A61K47/12 (EP,EA,IL,KR,US); A61K47/28 (EP,EA,IL,KR,US); A61K47/34 (EP,EA,IL,KR,US);
A61K9/107 (IL); A61K9/1075 (EP,EA,US); A61K9/51 (IL);
A61K9/5123 (CN,KR); A61P1/00 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P11/00 (EP); A61P13/12 (EP);
A61P15/00 (EP); A61P35/00 (EP); A61P35/02 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/09]
Former [2019/29]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA17.01.2020
ME17.01.2020
Validation statesMA17.01.2020
TitleGerman:THERAPEUTISCHE NANOPARTIKEL MIT EINEM BEHANDLUNGSMITTEL SOWIE VERFAHREN ZUR HERSTELLUNG UND VERWENDUNG DAVON[2019/29]
English:THERAPEUTIC NANOPARTICLES COMPRISING A THERAPEUTIC AGENT AND METHODS OF MAKING AND USING SAME[2019/29]
French:NANOPARTICULES THÉRAPEUTIQUES COMPORTANT UN AGENT THÉRAPEUTIQUE, ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION[2019/29]
Examination procedure17.01.2020Examination requested  [2020/09]
17.01.2020Date on which the examining division has become responsible
03.06.2020Communication of intention to grant the patent
03.09.2020Fee for grant paid
03.09.2020Fee for publishing/printing paid
03.09.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP15713285.3  / EP3116547
Opposition(s)15.07.2021No opposition filed within time limit [2021/38]
Fees paidRenewal fee
07.06.2019Renewal fee patent year 03
07.06.2019Renewal fee patent year 04
07.06.2019Renewal fee patent year 05
31.03.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.03.2015
AL14.10.2020
AT14.10.2020
CY14.10.2020
CZ14.10.2020
EE14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
MK14.10.2020
MT14.10.2020
PL14.10.2020
RO14.10.2020
RS14.10.2020
SI14.10.2020
SK14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
LU13.03.2021
CH31.03.2021
LI31.03.2021
[2024/42]
Former [2024/23]HU13.03.2015
AL14.10.2020
AT14.10.2020
CY14.10.2020
CZ14.10.2020
EE14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
MK14.10.2020
PL14.10.2020
RO14.10.2020
RS14.10.2020
SI14.10.2020
SK14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
LU13.03.2021
CH31.03.2021
LI31.03.2021
Former [2023/33]HU13.03.2015
AL14.10.2020
AT14.10.2020
CY14.10.2020
CZ14.10.2020
EE14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
PL14.10.2020
RO14.10.2020
RS14.10.2020
SI14.10.2020
SK14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
LU13.03.2021
CH31.03.2021
LI31.03.2021
Former [2023/30]AL14.10.2020
AT14.10.2020
CY14.10.2020
CZ14.10.2020
EE14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
PL14.10.2020
RO14.10.2020
RS14.10.2020
SI14.10.2020
SK14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
LU13.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/23]AL14.10.2020
AT14.10.2020
CZ14.10.2020
EE14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
PL14.10.2020
RO14.10.2020
RS14.10.2020
SI14.10.2020
SK14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
LU13.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/10]AL14.10.2020
AT14.10.2020
CZ14.10.2020
EE14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
PL14.10.2020
RO14.10.2020
RS14.10.2020
SI14.10.2020
SK14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
PT15.02.2021
LU13.03.2021
CH31.03.2021
LI31.03.2021
Former [2022/09]AL14.10.2020
AT14.10.2020
CZ14.10.2020
EE14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
PL14.10.2020
RO14.10.2020
RS14.10.2020
SI14.10.2020
SK14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
LU13.03.2021
Former [2021/50]AL14.10.2020
AT14.10.2020
CZ14.10.2020
EE14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
PL14.10.2020
RO14.10.2020
RS14.10.2020
SI14.10.2020
SK14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
Former [2021/45]AL14.10.2020
AT14.10.2020
CZ14.10.2020
EE14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
MC14.10.2020
PL14.10.2020
RO14.10.2020
RS14.10.2020
SK14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
Former [2021/36]AT14.10.2020
CZ14.10.2020
EE14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
PL14.10.2020
RO14.10.2020
RS14.10.2020
SK14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
Former [2021/35]AT14.10.2020
CZ14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
PL14.10.2020
RO14.10.2020
RS14.10.2020
SK14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
Former [2021/33]AT14.10.2020
HR14.10.2020
LT14.10.2020
LV14.10.2020
PL14.10.2020
RS14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
Former [2021/32]AT14.10.2020
HR14.10.2020
LV14.10.2020
PL14.10.2020
RS14.10.2020
SM14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
Former [2021/28]AT14.10.2020
HR14.10.2020
LV14.10.2020
PL14.10.2020
RS14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
Former [2021/25]AT14.10.2020
LV14.10.2020
PL14.10.2020
RS14.10.2020
BG14.01.2021
GR15.01.2021
IS14.02.2021
PT15.02.2021
Former [2021/23]AT14.10.2020
LV14.10.2020
RS14.10.2020
BG14.01.2021
GR15.01.2021
PT15.02.2021
Former [2021/22]RS14.10.2020
PT15.02.2021
Former [2021/21]PT15.02.2021
Documents cited:Search[A] US8206747  (ZALE STEPHEN E et al.)
 [A]   VENKATESAN A.M. ET AL.: "Bis(morpholino-1,3,5-triazine) derivatives: potent adenosine 5'-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: discovery of compound 26 (PKI-587), a highly efficacious dual inhibitor", J. MED. CHEM., vol. 53, 2010, pages 2636 - 2645, XP002739637

DOI:   http://dx.doi.org/10.1021/jm901830p
by applicantUS8039469
 US8206747
   J. CHEM. INFORM. MODEL, vol. 49, no. 12, 2009, pages 2801 2812
   SLEIN MW: "Methods of Enzymatic Analysis", 1974, ACADEMIC PRESS, pages: 1196 - 1201
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.